Gartner's 2028 Quantum Verdict: Real Tech, Early Investment Thesis

Gartner's 2028 call highlights the gap between quantum progress and enterprise demand

Here's the conflict in plain English: quantum hardware may one day become a real enterprise technology, but the market is trading some quantum stocks as if the category already has near-term AI revenue. Gartner's view cuts to the heart of that gap: no enterprise AI workload at scale will run on quantum hardware by 2028. That does not mean the science is fake. It means the investment case is being sold too early.

Earnings show the commercial gap

Earlier this month, IonQ, Rigetti, and D-Wave reported earnings back to back. That mattered because it pushed investors to look past the narrative and examine the business reality. Rigetti's revenue base is still tiny. According to the same source, first-quarter revenue was just $4.4 million, mostly from one-off hardware sales to universities and government labs. That is a long way from the recurring enterprise demand investors need to underpin a durable long-term thesis.

The clean read is simple: treat quantum as a long-horizon science race. The risk is paying 2027 prices for 2035 promises.

Why this is mainly a timing and monetization problem

The mistake investors keep making is confusing a lab win with a business win. That is a classic hype-cycle problem. A field can feature real science and real engineering talent and still produce nothing that clears the commercial test.

A useful comparison is the broader AI market. Even where AI spending is already substantial, less than 30% of AI leaders report their CEOs are happy with AI investment return. Quantum is not being judged as a niche curiosity; it is increasingly sold as the next AI upside story. If enterprises are still struggling to prove ROI on existing AI, that weakens the case that they are about to adopt quantum for production workloads.

Where bulls and bears actually disagree

Bulls can fairly say the science is not imaginary. Quantum systems may one day do things classical computers cannot. The leap is from possible to profitable. Gartner's point is practical, not dismissive: fault-tolerant quantum computing at a useful scale still needs progress in hardware, error correction, middleware and algorithms. That is four major stack layers, not one clear product-market fit.

Commercially, the sector still struggles with the same basic question: does this create repeatable value, or mostly compelling demos? Rigetti is the starkest example available in the cited evidence: first-quarter revenue was just $4.4 million, and it was mostly one-off hardware sales to universities and government labs. That is not the same as sustained enterprise demand.

Watch these signals instead:

• Recurring customer revenue, not just one-off lab or government hardware sales.
• Real-world utility beyond benchmark headlines and proof-of-concept projects.
• Stack integration, not only higher qubit counts.
• Budget discipline from enterprises before investors buy a "must not miss quantum" narrative.

For investors, the key filter is simple: is this technology close to production, or is it still early on the hype curve? That distinction helps separate the innovation trigger from genuine adoption. Right now, quantum looks closer to the trigger than to the profit stage.

How to approach the trade without buying the full narrative

The more disciplined move is basket exposure, not hero picking. Washington's about $2 billion commitment and equity stakes changed the setup. Investors finally had something more tangible than lab headlines, and the market responded immediately: Rigetti, IonQ, D-Wave, IBM and related names rallied on the funding reports. That re-rating is understandable. Government support can keep more companies funded and make the group more attractive before commercial proof is in.

Government backing helps, but it is not the same as enterprise demand

Policy support is an enabler, not an endorsement of today's pricing. Even the strongest balance sheets in the group can still sit beside very low revenue. One recent review highlighted Rigetti's cash position, but also noted it remains a long way from generating recurring revenue. That is the test investors still need to see.

The opportunity may come from owning the basket early, while the market is still paying for industrial-policy backing and milestone hope. The next leg higher likely arrives when investors begin rewarding repeatable customers, not just breakthrough announcements. In that context, larger names such as IBM may offer more stability, while pure plays could still outperform if one eventually turns lab progress into steady enterprise uptake.

Stay exposed to the long-term possibility, but size for volatility and keep demanding proof that quantum is moving from government-backed promise to customer-paid reality.